ArticleAnnals of translational medicine2021

Matched pair analysis for comparison of survival outcome of alternative regimens to standard three-weekly cisplatin-based concurrent chemoradiation of head and neck cancer.

Hye Ri Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.